N-(4-AMino-6,7-diMethoxyquinazol-2-yl)-N-MethylpropylenediaMine ForMaMide Hydrochloride
N-(4-AMino-6,7-diMethoxyquinazol-2-yl)-N-MethylpropylenediaMine ForMaMide Hydrochloride(1026411-59-5)
- Name: N-(4-AMino-6,7-diMethoxyquinazol-2-yl)-N-MethylpropylenediaMine ForMaMide Hydrochloride
- Synonyms:N-(4-AMino-6,7-diMethoxyquinazol-2-yl)-N-MethylpropylenediaMine ForMaMide Hydrochloride
- Molecular Formula:C15H21N5O3
- Molecular Weight:355.81988
- CAS Registry Number:1026411-59-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1026411-59-5 Alfuzosin Hydrochloride Impurity E
Assay:99%min. Appearance:white powder Package:1kg/Export worthy packing; 25kg/drum Storage:In well-closed container, protected from light and in cool & dry place. Transportation:By Air, By Sea, By courier (door to door, DHL/FedEx/UPS) Application:R&D and production for pharmaceuticals and chemicals
Min. Order:1Gram
Supplier:LIDE PHARMACEUTICALS LIMITED [
China (Mainland)] CAS No.1026411-59-5 Alfuzosin Impurity E HCl
Assay:> 95% Appearance:White to Off-White Solid Package:inquiry Transportation:inquiry Application:An impurity of Alfuzosin
Min. Order:1Gram
Supplier:BOC Sciences [
United States] CAS No.1026411-59-5 Alfuzosin EP Impurity E CAS No.1026411-59-5
Assay:99.90% Appearance:solid or liquid Package:As customer's requested Storage:sealed in cool and dry place Transportation:by courier/air/sea Application:Pharma Intermediate
Min. Order:0
Supplier:Guangdong Juda Chemical Industrial Co.,Limited [
China (Mainland)]
Other Product
- 1000207-52-2/tert-butyl 4-(2-chloro-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino)piperidine-1-carboxylate
- 1097920-64-3/1-(7-chloro-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone
- 406193-87-1/1H-Imidazole-4-sulfonic acid, 2-amino- (9CI)
- 611207-11-5/LH 21
- 732974-79-7/Acetamide, 2-[(aminoiminomethyl)methylamino]- (9CI)
- 77702-20-6/N-Methyl-L-Tyr-4-(methylsulfinyl)-D-Abu-Gly-[(S)-1-(hydroxymethyl)-2-phenylethyl]-NH2
- 753005-89-9/4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-[2-(4-ethyl-1-piperazinyl)ethoxy-]-6-methoxy-3-quinolinecarbonitrile
- 68512-90-3/Diesel fuels
- 861526-61-6/4-BroMo-2-MethylaMino-benzoic acid
- 205823-24-1/Methyl 2'-formyl[1,1'-biphenyl]-4-carboxylate
- 118606-97-6/reuterin
- 1131041-71-8/5-bromo-6-chloro-2-nitro-3-Pyridinol
- 339224-99-6/4(1H)-Pyridinimine,1-propyl-(9CI)
- 287100-61-2/1,4-Butanediamine-1,4-13C2, Putrescine-1,4-13C2
- 1009094-73-8/3-aMino-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
- 1173023-05-6/Pentanoic acid-3,4,5-13C3
- 1322008-41-2/JWH 073 N-(4-hydroxybutyl) β-D-Glucuronide
- 37772-93-3/5-Methylpyrrolidine-2,4-dione
- 80053-54-9/2-ETHYLHEXAHYDRO-1H-AZEPINE
- 1026411-59-5/N-(4-AMino-6,7-diMethoxyquinazol-2-yl)-N-MethylpropylenediaMine ForMaMide Hydrochloride
- 1058737-58-8/tert-butyl 2,4-bis(hydroxyMethyl)pyrrolidine-1-carboxylate
- 1073477-06-1/1-(4-Hydroxy-phenyl)-cyclopropanecarbonitrile
- 1227060-32-3/ETHYL 2-ACETAMIDO-2-(DIMETHOXYPHOSPHORYL)ACETATE
- 1227268-94-1/1-Benzenesulfonyl-5-iodo-1H-pyrrolo[2,3-b]pyridine
- 1226808-72-5/Ethyl 2-(5-bromo-2-methylphenyl)-2,2-difluoroacetate
- 158261-95-1/3-(1-PYRROLIDINYL)-1-BUTANOL
- 485317-07-5/Benzeneacetamide, N-(2,6-dimethylphenyl)-alpha-[propyl[4-(1H-tetrazol-1-yl)benzoyl]amino]- (9CI)
- 70844-48-3/Methotrexate Related Compound E (50 mg) (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
- 79617-98-4/(1R,4R)-Sertraline HCl
- 947534-78-3/6-(4-Iodo-phenyl)-3-methyl-imidazo[1,2-d][1,2,4]thiadiazole